You are here

  • Home
  • Archive
  • Volume 8, Issue Suppl 3
  • 223 Racial differences in outcomes for metastatic renal cell carcinoma (mRCC) patients managed on immune-checkpoint inhibitor (ICI) therapy

Article metrics

Article menu

Download PDFPDF

Regular and young investigator award abstracts
Checkpoint blockade therapy
223 Racial differences in outcomes for metastatic renal cell carcinoma (mRCC) patients managed on immune-checkpoint inhibitor (ICI) therapy

 

Online download statistics by month:

Online download statistics by month: November 2020 to August 2024

AbstractFullPdf
Nov 20208607
Dec 20203904
Jan 20211702
Feb 20212604
Mar 20216806
Apr 20212803
May 2021504
Jun 2021005
Jul 2021009
Aug 2021003
Sep 2021008
Oct 202112021
Nov 202121013
Dec 20211601
Jan 2022801
Feb 20221302
Mar 20221000
Apr 20223601
May 20221204
Jun 20221804
Jul 20222003
Aug 20221103
Sep 20222101
Oct 20223400
Nov 20222104
Dec 20221200
Jan 20231200
Feb 20231400
Mar 2023801
Apr 2023407
May 2023400
Jun 2023400
Jul 2023401
Aug 20231401
Sep 20231201
Oct 20233006
Nov 20231003
Dec 20232000
Jan 2024600
Feb 20241200
Mar 2024800
Apr 2024800
May 20243203
Jun 20242200
Jul 20241400
Aug 20241001
Total7820137